identification of bacteria-derived hla-bound peptides in melanoma derived - category-2-peptides derived Unveiling Bacterial Signatures: Identification of Bacteria-Derived HLA-Bound Peptides in Melanoma

idenel-altum-peptide-solution-cream The identification of bacteria-derived HLA-bound peptides in melanoma represents a significant advancement in understanding the complex interplay between the tumor microenvironment and the host immune system. Recent research has demonstrated that peptides originating from intracellular bacteria can be presented by tumor cells, specifically on Human Leukocyte Antigen (HLA) class I and II molecules.作者：R Naghavian·2023·被引用次数：148—We demonstrate thatHLAmolecules of both glioblastoma tissues and tumour cell lines presentbacteria-specificpeptides. This finding prompted us to examine ... This presentation of bacterial peptides on melanoma cells offers a novel avenue for immune recognition and potential therapeutic targeting2021年3月23日—The HLA peptidomics analysis revealed 248 peptides (35 unique) from 41 different bacteria on the surface of the melanoma cells..

The Role of Bacterial Peptides in Melanoma

Melanoma, a form of skin cancer known for its immunogenicity, is increasingly being studied in the context of its associated microbiome. Studies analyzing melanoma metastases have revealed a substantial number of unique HLA-I and HLA-II peptides derived from various bacteria residing within the tumorHLA peptidomic analysis identifies recurrent intracellular bacteria-derived peptidespresented on HLA-I and HLA-II molecules in melanoma tumours, revealing how .... For instance, one comprehensive analysis identified 248 unique HLA-I and 35 unique HLA-II peptides originating from 41 different bacterial species. This finding underscores the potential for these bacterial peptides to act as neoantigens, eliciting an immune response against the tumor.

The presentation of these bacterial peptides on the surface of melanoma cells through HLA molecules suggests a mechanism by which the immune system might distinguish between healthy and cancerous tissue, or conversely, how tumors might evade immune surveillance by presenting "foreign" bacterial antigensBacteria inside melanoma tumors may offer clues about cancer outcomes. Understanding which specific bacterial peptides are presented and how they are recognized by T cells is crucial for developing new immunotherapies.

Mechanisms of Presentation and Immune Reactivity

The process by which bacterial peptides become bound to HLA molecules and presented on melanoma cells involves several steps. Intracellular bacteria within tumor cells can be processed, and their peptide fragments can enter the MHC (Major Histocompatibility Complex) presentation pathway.作者：A Du Toit·2021·被引用次数：2—The analysis revealed 248 unique HLA-I-associated peptides and 35 unique HLA-II-associated peptides, which suggests that melanoma cells present ... HLA molecules, which are highly polymorphic, bind these peptides and display them on the cell surface.672 Identification of microbial-derived HLA-bound peptides ... This presentation is critical for T cell recognition.

Research has shown that peptides derived from intracellular bacteria can indeed elicit immune reactivity2021年3月23日—The HLA peptidomics analysis revealed 248 peptides (35 unique) from 41 different bacteria on the surface of the melanoma cells.. This means that the immune system, particularly T cells, can recognize these bacterial peptides as foreign or aberrant when presented by melanoma cells. This recognition can lead to an anti-tumor immune response, potentially contributing to tumor control or rejection作者：C Perreault·2021·被引用次数：5—A recent Nature paper by Kalaora et al. 4 describes theidentificationof intracellularbacteriathat alter the antigenic characteristics of human melanomas.. Conversely, the presence of certain bacterial peptides might also contribute to immune tolerance or suppression, depending on the context and the specific peptides involved.

Implications for Melanoma Treatment and Research

The identification and characterization of bacteria-derived HLA-bound peptides in melanoma have significant implications for future research and clinical applications作者：GD Sepich-Poore·2021·被引用次数：20—By revealing potentially immunogenicbacterial peptidesonmelanomacells, a Nature paper provides evidence that intratumoralbacteriacan ....

* Neoantigen Discovery: These bacterial peptides represent a novel class of neoantigens that could be exploited for cancer immunotherapy. By identifying specific bacterial peptides that are frequently presented on melanoma cells and are immunogenic, researchers can develop targeted vaccines or T cell therapies aimed at stimulating a robust anti-melanoma immune responseAnti-tumor immunity induces aberrant peptide presentation in melanoma. Nature ... et al.Identification of bacteria-derived HLA-bound peptides in melanoma..

* Biomarker Development: The presence or abundance of certain bacteria-derived peptides might serve as a biomarker for predicting patient prognosis or response to immunotherapyFingerprint. Dive into the research topics of 'Identification of bacteria-derived HLA-bound peptides in melanoma'. Together they form a unique fingerprint.. This could allow for more personalized treatment strategies.

* Understanding Tumor Microenvironment: This research sheds light on the intricate relationship between the tumor and its microbial inhabitants.作者：H Ikeda·1997·被引用次数：985—When we tested the lytic activity of CTL 17 on a panel ofHLA-A24melanomacell lines expressing the PRAME gene at a high level, we observed that some of these. It suggests that the tumor microbiome is not merely a bystander but actively participates in shaping the tumor's antigenic landscape and influencing the host immune response作者：M Bassani-Sternberg·2016·被引用次数：782—We detected the highest number of TAA-derived peptideligands for the well-knownmelanoma-associated antigen PMEL. (gp100), (64HLAI and 46HLA....

* Therapeutic Strategies: Further investigation into how to manipulate the presentation of these bacterial peptides or how to enhance the immune response against them could lead to novel therapeutic interventions作者：S Kalaora·2021·被引用次数：415—Our study reveals thatpeptides derived from intracellular bacteria can be presented by tumourcells and elicit immune reactivity.. For example, strategies could focus on altering the tumor microbiome to favor the presentation of immunogenic peptides or developing T cell receptors that specifically recognize these bacterial-derived epitopes作者：Y Wang·2025—Identification of bacteria-derived HLA-bound peptides in melanoma. Nature. 592, 138–143 (2021). 4. Kalaora, S. et al. Identification of ....

In conclusion, the ongoing identification of bacteria-derived HLA-bound peptides in melanoma is a rapidly evolving field that promises to deepen our understanding of cancer immunology and open new avenues for therapeutic innovation.Identification of bacteria-derived HLA-bound peptides in ... The discovery that peptides originating from intracellular bacteria can be presented by tumor cells and trigger immune responses highlights the critical role of the tumor microbiome in shaping the host-cancer dialogue.